Terms: = Skin cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Treatment
191 results:
1. [Effect of Low-Dose Recombinant Interleukin-2 Therapy on Immunocyte Subsets in Children with Solid Tumor].
Lei JY; Li Y; Li CM; Xiong XL; Feng CC; Weng WJ; Peng XM; Zhou DH; Huang K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):445-449. PubMed ID: 38660850
[TBL] [Abstract] [Full Text] [Related]
2. Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis.
Yamada K; Takeuchi M; Fukumoto T; Suzuki M; Kato A; Mizuki Y; Yamada N; Kaneko T; Mizuki N; Horita N
Sci Rep; 2024 Apr; 14(1):7887. PubMed ID: 38570507
[TBL] [Abstract] [Full Text] [Related]
3. Regulation of Cell Cycle Progression through RB Phosphorylation by Nilotinib and AT-9283 in Human Melanoma A375P Cells.
Pham TM; Ahmed M; Lai TH; Bahar ME; Hwang JS; Maulidi RF; Ngo QN; Kim DR
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474202
[TBL] [Abstract] [Full Text] [Related]
4. Increase in the Life Expectancy of Patients with cancer in the United States.
Devasia TP; Howlader N; Dewar RA; Stevens JL; Mittu K; Mariotto AB
Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):196-205. PubMed ID: 38015774
[TBL] [Abstract] [Full Text] [Related]
5. Targetable lesions and proteomes predict therapy sensitivity through disease evolution in pediatric acute lymphoblastic leukemia.
Lorentzian AC; Rever J; Ergin EK; Guo M; Akella NM; Rolf N; James Lim C; Reid GSD; Maxwell CA; Lange PF
Nat Commun; 2023 Nov; 14(1):7161. PubMed ID: 37989729
[TBL] [Abstract] [Full Text] [Related]
6. Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for Breast cancer Metastasis Inhibition.
Zou J; Sun R; He M; Chen Y; Cheng Y; Xia C; Ma Y; Zheng S; Fu X; Yuan Z; Lan M; Lou K; Chen X; Gao F
ACS Appl Mater Interfaces; 2023 Nov; 15(46):53198-53216. PubMed ID: 37942626
[TBL] [Abstract] [Full Text] [Related]
7. Multiple Myeloma in Adolescent and Young Adults: An ASCO cancerLinQ and SEER Analysis.
Gibson S; Thornton J; Sunderland K; Pham K; DeStefano C
Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):e335-e340. PubMed ID: 37541820
[TBL] [Abstract] [Full Text] [Related]
8. Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors.
Ding L; Sun L; Bu MT; Zhang Y; Scott LN; Prins RM; Su MA; Lechner MG; Hugo W
Front Immunol; 2023; 14():1176994. PubMed ID: 37435085
[TBL] [Abstract] [Full Text] [Related]
9. [Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
Cheng P; Wang QX; Wang LL; Guan J; Zhou Y; Zhang T; Su F; Chen LQ; Cao Y; Cheng H; Zou L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):896-901. PubMed ID: 37356957
[TBL] [Abstract] [Full Text] [Related]
10. A Necroptosis-Related Gene Signature to Predict the Prognosis of skin Cutaneous Melanoma.
Xie Y; Xu Z; Mei X; Shi W
Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
[TBL] [Abstract] [Full Text] [Related]
11. Concomitant Use of Ado-trastuzumab Emtansine and Imatinib in a Patient of cml and Metastatic Breast cancer.
Karacin C; Bilgetekin I; Basal FB; Oksuzoglu OB
J Coll Physicians Surg Pak; 2022 Nov; 32(11):1501-1502. PubMed ID: 36377026
[TBL] [Abstract] [Full Text] [Related]
12. Changes in the Immune Cell Repertoire for the treatment of Malignant Melanoma.
Nakamura K; Okuyama R
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361781
[TBL] [Abstract] [Full Text] [Related]
13. Case Report: Successful engraftment of allogeneic hematopoietic stem cells using CAR-T cell therapy as the conditioning regimen in R/R Ph
Han L; Zhao R; Yang J; Zu Y; Liu Y; Zhou J; Li L; Huang Z; Zhang J; Gao Q; Song Y; Zhou K
Front Immunol; 2022; 13():965932. PubMed ID: 36225940
[TBL] [Abstract] [Full Text] [Related]
14. Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
Jiang Q; Li Z; Qin Y; Li W; Xu N; Liu B; Zhang Y; Meng L; Zhu H; Du X; Chen S; Liang Y; Hu Y; Liu X; Song Y; Men L; Chen Z; Niu Q; Wang H; Lu M; Yang D; Zhai Y; Huang X
J Hematol Oncol; 2022 Aug; 15(1):113. PubMed ID: 35982483
[TBL] [Abstract] [Full Text] [Related]
15. A systematic review of recent trends in research on therapeutically significant L-asparaginase and acute lymphoblastic leukemia.
Suresh SA; Ethiraj S; Rajnish KN
Mol Biol Rep; 2022 Dec; 49(12):11281-11287. PubMed ID: 35816224
[TBL] [Abstract] [Full Text] [Related]
16. Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases.
Sneed PK; Chan JW; Ma L; Braunstein SE; Theodosopoulos PV; Fogh SE; Nakamura JL; Boreta L; Raleigh DR; Ziemer BP; Morin O; Hervey-Jumper SL; McDermott MW
J Neurosurg; 2023 Jan; 138(1):104-112. PubMed ID: 35594891
[TBL] [Abstract] [Full Text] [Related]
17. skin and soft tissue infections in adolescent chronic myeloid leukemia under dasatinib treatment.
Uchida E; Saito S; Morita D; Okura E; Hirabayashi K; Tanaka M; Nakazawa H; Minagawa A; Nakazawa Y
Pediatr Blood Cancer; 2022 Aug; 69(8):e29714. PubMed ID: 35441424
[TBL] [Abstract] [Full Text] [Related]
18. Erythroderma: An unusual manifestation of imatinib - A rare case report.
Kataria P; Patel A; Kendre P; Tahiliani N; Mule T; Bohra M
J Cancer Res Ther; 2022; 18(1):253-256. PubMed ID: 35381793
[TBL] [Abstract] [Full Text] [Related]
19. Phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (cKS).
Zer A; Icht O; Yosef L; Avram D; Jacobi O; Fenig E; Kurman N; Peretz I; Shamai S; Merimsky O; Ben-Ami E; Shapira Frommer R; Schwarzbach AE; Bernstine H; Weitzen R; Vornicova O; Bar-Sela G; Stemmer SM; Lotem M
Ann Oncol; 2022 Jul; 33(7):720-727. PubMed ID: 35339649
[TBL] [Abstract] [Full Text] [Related]
20. [Efficacy analysis of Venetoclax combined with TKI and dexamethasone-containing low-dose chemotherapy for relapsed/refractory Ph
Tian Y; Ai H; Ji X; Wei XD; Song YP; Yin QS
Zhonghua Yi Xue Za Zhi; 2022 Mar; 102(10):745-748. PubMed ID: 35280020
[TBL] [Abstract] [Full Text] [Related]
[Next]
